In this issue:
Airway inflammation in Indigenous vs non-Indigenous Australians with asthma or COPD
Long-term risk of mortality after COVID-19 recovery in COPD patients
Oral corticosteroid-related healthcare resource utilisation in COPD patients
Serum immunoglobulin G levels are associated with exacerbation risk
Targeted Pulmozyme treatment in patients with obstructive lung disease
Benefits of chest wall mobilisation for severe COPD
Effect of triple therapy on cardiovascular and cardiopulmonary events in COPD
ICSs and major cardiovascular events in patients with COPD
Complication rates of bronchoscopic lung volume reduction for severe emphysema
GOLD Science Committee recommendations for the diagnostic use of spirometry
Please login below to download this issue (PDF)